Acessibilidade / Reportar erro

Antimicrobial susceptibility associated with bloodstream infections in children: a referral hospital-based study

LETTER TO THE EDITOR

Antimicrobial susceptibility associated with bloodstream infections in children: a referral hospital-based study

Mohammad Taghi Haghi AshtianiI; Setareh MamishiII; Ahmad MasoomiI; Nafiseh NasiriI; Mohammad HosseiniI; Bahram NikmaneshI; Babak PourakbariII; Nima RezaeiIII,IV,V,* * Corresponding author at: Children's Medical Center Hospital, 62 Qarib St, Keshavarz Blvd, Tehran 14194, Iran. E-mail address: rezaei_nima@tums.ac.ir (N. Rezaei).

IPediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

IIPediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran

IIIResearch Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

IVMolecular Immunology Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

VDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Dear Editor,

Bacterial pathogens are becoming more and more resistant to antibiotics used commonly by healthcare practitioners. Despite introduction of new antibiotics, empiric treatment of patients with bloodstream infections (BSIs) became a major challenge for practicing physicians.1,2

To depict the susceptibility patterns of BSI pathogens endemic in a referral pediatric hospital, Children's Medical Center (Tehran, Iran), the antimicrobial susceptibility patterns among 3593 patients were reviewed in a 5-year period (2006-2010). Bacterial identification and disk diffusion susceptibility testing were performed, using standard methods.3

Percentages of Gram positive and Gram negative bacteria were 35% (1265/3593) and 65% (2328/3593), respectively. Enterobacter spp. (25.9%), Pseudomonas aeroginosa (25.5%), and Coagulase-negative staphylococci (CoNS) (23.2%) were the most frequent agents, followed by Staphylococcus aureus (6.2%) and Klebsiella spp. (5.9%), collectively accounting for 87% of all BSI blood isolates cultured. were Staphylococcus spp., followed by Viridans group streptococci, Streptococcus pneumonia, and Entro coccus spp. comprised about 84% of all Gram positive bacteria isolated from blood cultures. Among Gram negative bacteria, Enterbacter spp., Pseudomonas aeruginosa, Klebsiella spp., E. coli, and Salmonella spp. accounted for about 95% of isolates. Table 1 shows the antimicrobial susceptibility pattern of Gram positive and Gram negative bacteria in this study. CoNS are almost always resistant to oxacillin. Furthermore, the rate of susceptibility is very low among S. aureus (13.2%) and S. pneumoniae (7%). Vancomycin showed an acceptable antibiotic effect on CoNS, S. aureus, S. pneumoniae and viridans group Streptococci, with susceptibility rates of 93.2%, 95.3%, 96.4% and 92.7%, respectively. Among staphylococcal isolates S. aureus was more susceptible to clindamycin (82.9% versus 52.9%) and to trimethoprim/sulfamethoxazole (60.9% versus 34.0%) than CoNS. S. pneumoniae was highly susceptible to ceftriaxone (93.9%), cefalotin (96.6%), and vancomycin (96.4%). About half of the Klebsiella spp. isolates tested were resistant to amikacin. The rate of resistance to ampicillin, ceftriaxone and piperacillin-tazobactam was as high as 97.7%, 66.7% and 35.4%, respectively. The rate of E. coli resistance to amikacin was similar to that of Klebsiella spp. On the contrary, Imipenem showed to be quite effective in both organisms (Table 1).

Although bacteriologic culture is the keystone of management of septicemia, culture result takes time; therefore, understanding the regional bacterial susceptibility and pattern of resistance to antimicrobial agents is very important to prepare treatment guidelines. In two previous studies conducted in the same hospital during 1995-2000 and 2001-2005, the prevalence of Gram positive bacteria was reported as 72.0% and 47.6%, respectively.4,5 However, the recent data showed that the Gram negative microorganisms have become much more prevalent. These data also show that the pattern of antimicrobial resistance in Iran is different from other parts of the world. Thus, based on the observed changes therapeutic regimens prescribed by health practitioners in Iran should be modified.

Conflict of interest

The authors declare no conflict of interest.

Received 26 December 2012

Accepted 2 January 2013

Available online 25 June 2013

  • 1. Shlaes DM, Gerding DN, John Jr JF, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25:584-99.
  • 2. Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother. 1998;42:1762-70.
  • 3. Wikler MA. Performance standards for antimicrobial disk susceptibility tests: approved standard. Clinical and Laboratory Standards Institute; 2006.
  • 4. Mamishi S, Pourakbari B, Ashtiani MH, Hashemi FB. Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000. Int J Antimicrob Agents. 2005;26: 373-9.
  • 5. Pourakbari B, Sadr A, Ashtiani MT, et al. Five-year evaluation of the antimicrobial susceptibility patterns of bacteria causing bloodstream infections in Iran. J Infect Dev Countries. 2012;6:120-5.
  • *
    Corresponding author at: Children's Medical Center Hospital, 62 Qarib St, Keshavarz Blvd, Tehran 14194, Iran. E-mail address:
  • Publication Dates

    • Publication in this collection
      16 Aug 2013
    • Date of issue
      Aug 2013
    Brazilian Society of Infectious Diseases Rua Augusto Viana, SN, 6º., 40110-060 Salvador - Bahia - Brazil, Telefax: (55 71) 3283-8172, Fax: (55 71) 3247-2756 - Salvador - BA - Brazil
    E-mail: bjid@bjid.org.br